Pancreatic Cancer Heterogeneity Can Be Explained Beyond the Genome

por Juiz, Natalia Anahi, Iovanna, Juan, Dusetti, Nelson
Publicado 2019

Emerging epigenomic landscapes of pancreatic cancer in the era of precision medicine

por Lomberk, Gwen, Dusetti, Nelson, Iovanna, Juan, Urrutia, Raul
Publicado 2019

Limitation and challenges in using pancreatic cancer‐derived organoids as a preclinical tool

por Fraunhoffer, Nicolas A., Abuelafia, Analía Meilerman, Dusetti, Nelson, Iovanna, Juan
Publicado 2022

Redox-sensitive TP53INP1 SUMOylation as an oxidative stress sensor to activate TP53

por Bonacci, Thomas, Peuget, Sylvain, Soubeyran, Philippe, Iovanna, Juan, Dusetti, Nelson J
Publicado 2014

Induction of Apoptosis in Human Pancreatic Cancer Stem Cells by the Endoplasmic Reticulum-Targeted Alkylphospholipid Analog Edelfosine and Potentiation by Autophagy Inhibition

por Gajate, Consuelo, Gayet, Odile, Fraunhoffer, Nicolas A., Iovanna, Juan, Dusetti, Nelson, Mollinedo, Faustino
Publicado 2021

Selection of Intracellular Single-Domain Antibodies Targeting the HIV-1 Vpr Protein by Cytoplasmic Yeast Two-Hybrid System

por Matz, Julie, Hérate, Cécile, Bouchet, Jérôme, Dusetti, Nelson, Gayet, Odile, Baty, Daniel, Benichou, Serge, Chames, Patrick
Publicado 2014

CDK2 and PKA Mediated-Sequential Phosphorylation Is Critical for p19INK4d Function in the DNA Damage Response

por Marazita, Mariela C., Ogara, M. Florencia, Sonzogni, Silvina V., Martí, Marcelo, Dusetti, Nelson J., Pignataro, Omar P., Cánepa, Eduardo T.
Publicado 2012

Therapeutic advances in metastatic pancreatic cancer: a focus on targeted therapies

por Turpin, Anthony, Neuzillet, Cindy, Colle, Elise, Dusetti, Nelson, Nicolle, Rémy, Cros, Jérôme, de Mestier, Louis, Bachet, Jean-Baptiste, Hammel, Pascal
Publicado 2022

Inhibition of glucuronidation in pancreatic cancer improves gemcitabine anticancer activity

por Fraunhoffer, Nicolas Alejandro, Abuelafia, Analía Meilerman, Chanez, Brice, Bigonnet, Martin, Gayet, Odile, Roques, Julie, Chuluyan, Eduardo, Dusetti, Nelson, Iovanna, Juan
Publicado 2022

Targeting CD44 as a novel therapeutic approach for treating pancreatic cancer recurrence

por Molejon, Maria Inés, Tellechea, Juan Ignacio, Moutardier, Vincent, Gasmi, Mohamed, Ouaissi, Mehdi, Turrini, Olivier, Delpero, Jean-Robert, Dusetti, Nelson, Iovanna, Juan
Publicado 2015

Prognostic significance of circulating PD-1, PD-L1, pan-BTN3As, BTN3A1 and BTLA in patients with pancreatic adenocarcinoma

por Bian, Benjamin, Fanale, Daniele, Dusetti, Nelson, Roque, Julie, Pastor, Sonia, Chretien, Anne-Sophie, Incorvaia, Lorena, Russo, Antonio, Olive, Daniel, Iovanna, Juan
Publicado 2019

Pancreatic Cancer Organoids for Determining Sensitivity to Bromodomain and Extra-Terminal Inhibitors (BETi)

por Bian, Benjamin, Juiz, Natalia Anahi, Gayet, Odile, Bigonnet, Martin, Brandone, Nicolas, Roques, Julie, Cros, Jérôme, Wang, Nenghui, Dusetti, Nelson, Iovanna, Juan
Publicado 2019

Multi-omics data integration and modeling unravels new mechanisms for pancreatic cancer and improves prognostic prediction

por Fraunhoffer, Nicolas A., Abuelafia, Analía Meilerman, Bigonnet, Martin, Gayet, Odile, Roques, Julie, Nicolle, Remy, Lomberk, Gwen, Urrutia, Raul, Dusetti, Nelson, Iovanna, Juan
Publicado 2022

E2F signature is predictive for the pancreatic adenocarcinoma clinical outcome and sensitivity to E2F inhibitors, but not for the response to cytotoxic-based treatments

por Lan, Wenjun, Bian, Benjamin, Xia, Yi, Dou, Samir, Gayet, Odile, Bigonnet, Martin, Santofimia-Castaño, Patricia, Cong, Mei, Peng, Ling, Dusetti, Nelson, Iovanna, Juan
Publicado 2018

Metabolomic profiling of pancreatic adenocarcinoma reveals key features driving clinical outcome and drug resistance

por Kaoutari, Abdessamad El, Fraunhoffer, Nicolas A, Hoare, Owen, Teyssedou, Carlos, Soubeyran, Philippe, Gayet, Odile, Roques, Julie, Lomberk, Gwen, Urrutia, Raul, Dusetti, Nelson, Iovanna, Juan
Publicado 2021

The Functional Landscape of Hsp27 Reveals New Cellular Processes such as DNA Repair and Alternative Splicing and Proposes Novel Anticancer Targets

por Katsogiannou, Maria, Andrieu, Claudia, Baylot, Virginie, Baudot, Anaïs, Dusetti, Nelson J., Gayet, Odile, Finetti, Pascal, Garrido, Carmen, Birnbaum, Daniel, Bertucci, François, Brun, Christine, Rocchi, Palma
Publicado 2014

A glycosyltransferase gene signature to detect pancreatic ductal adenocarcinoma patients with poor prognosis

por Mohamed Abd-El-Halim, Yousra, El Kaoutari, Abdessamad, Silvy, Françoise, Rubis, Marion, Bigonnet, Martin, Roques, Julie, Cros, Jérôme, Nicolle, Rémy, Iovanna, Juan, Dusetti, Nelson, Mas, Eric
Publicado 2021

Dendrimer nanosystems for adaptive tumor-assisted drug delivery via extracellular vesicle hijacking

por Jiang, Yifan, Lyu, Zhenbin, Ralahy, Brigino, Liu, Juan, Roussel, Tom, Ding, Ling, Tang, Jingjie, Kosta, Artemis, Giorgio, Suzanne, Tomasini, Richard, Liang, Xing-Jie, Dusetti, Nelson, Iovanna, Juan, Peng, Ling
Publicado 2023

Pancreatic ductal adenocarcinoma ubiquitination profiling reveals specific prognostic and theranostic markers

por El Kaoutari, Abdessamad, Fraunhoffer, Nicolas A., Audebert, Stéphane, Camoin, Luc, Berthois, Yolande, Gayet, Odile, Roques, Julie, Bigonnet, Martin, Bongrain, Claire, Ciccolini, Joseph, Iovanna, Juan L., Dusetti, Nelson J., Soubeyran, Philippe
Publicado 2023

Cadherin-1 and cadherin-3 cooperation determines the aggressiveness of pancreatic ductal adenocarcinoma

por Siret, Carole, Dobric, Aurélie, Martirosyan, Anna, Terciolo, Chloé, Germain, Sébastien, Bonier, Renaté, Dirami, Thassadite, Dusetti, Nelson, Tomasini, Richard, Rubis, Marion, Garcia, Stéphane, Iovanna, Juan, Lombardo, Dominique, Rigot, Véronique, André, Frédéric
Publicado 2018